Literature DB >> 9629983

Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis.

H Peltroche-Llacshuanga, H Peltroche-Llacsahuanga, H Kentrup, G Haase.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9629983     DOI： 10.1007/bf01682173

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Restriction endonucleases for pulsed field mapping of bacterial genomes.

Authors:  M McClelland; R Jones; Y Patel; M Nelson
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

2.  Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.

Authors:  H Vu-Thien; D Moissenet; M Valcin; C Dulot; G Tournier; A Garbarg-Chenon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

3.  Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation.

Authors:  D Moissenet; A Baculard; M Valcin; V Marchand; G Tournier; A Garbarg-Chenon; H Vu-Thien
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

4.  In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Authors:  Y Glupczynski; W Hansen; J Freney; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxydans by DNA restriction fragment length polymorphism.

Authors:  M Cheron; E Abachin; E Guerot; M el-Bez; M Simonet
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Rüger and Tan 1983.

Authors:  P Vandamme; M Heyndrickx; M Vancanneyt; B Hoste; P De Vos; E Falsen; K Kersters; K H Hinz
Journal:  Int J Syst Bacteriol       Date:  1996-10

8.  Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction.

Authors:  W M Dunne; S Maisch
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

9.  Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.

Authors:  K Muhdi; F P Edenborough; L Gumery; S O'Hickey; E G Smith; D L Smith; D E Stableforth
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139
  9 in total
  11 in total

1.  Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation.

Authors:  Frédéric Wallet; Thierry Perez; Sylvie Armand; Benoit Wallaert; René J Courcol
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.

Authors:  Rosana H V Pereira; Ana Paula Carvalho-Assef; Rodolpho M Albano; Tania W Folescu; Marcia C M F Jones; Robson S Leão; Elizabeth A Marques
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

3.  Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.

Authors:  B D Edwards; J Greysson-Wong; R Somayaji; B Waddell; F J Whelan; D G Storey; H R Rabin; M G Surette; M D Parkins
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

4.  Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.

Authors:  Sabine Van Daele; Rita Verhelst; Geert Claeys; Gerda Verschraegen; Hilde Franckx; Leen Van Simaey; Catharine de Ganck; Frans De Baets; Mario Vaneechoutte
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 5.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.

Authors:  Lixia Liu; Tom Coenye; Jane L Burns; Paul W Whitby; Terrence L Stull; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone.

Authors:  M Kanellopoulou; S Pournaras; H Iglezos; N Skarmoutsou; E Papafrangas; A N Maniatis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

8.  Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.

Authors:  A Lambiase; M R Catania; M Del Pezzo; F Rossano; V Terlizzi; A Sepe; V Raia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-31       Impact factor: 3.267

9.  Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.

Authors:  Henrique Douglas M Coutinho; Vivyanne S Falcão-Silva; Gregório Fernandes Gonçalves
Journal:  Int Arch Med       Date:  2008-11-07

10.  Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.

Authors:  Tim Holm Jakobsen; Martin Asser Hansen; Peter Østrup Jensen; Lars Hansen; Leise Riber; April Cockburn; Mette Kolpen; Christine Rønne Hansen; Winnie Ridderberg; Steffen Eickhardt; Marlene Hansen; Peter Kerpedjiev; Morten Alhede; Klaus Qvortrup; Mette Burmølle; Claus Moser; Michael Kühl; Oana Ciofu; Michael Givskov; Søren J Sørensen; Niels Høiby; Thomas Bjarnsholt
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.